Contrast-induced nephropathy

Indian Heart Journal

Volumn 60, Issue 2, 2008, Pages 133-138

  Ray, Saumitra ^a,b   Dutta, Anjanlal ^a  

^a VIVEKANANDA INSTITUTE OF MEDICAL SCIENCES   (India)

^b NONE   (India)

Author keywords

Management; Nephropathy; Prevention; Radiocontrast media

Indexed keywords

ACETYLCYSTEINE; AMINOPHYLLINE; AMLODIPINE; ANTIOXIDANT; ASCORBIC ACID; BICARBONATE; CALCIUM CHANNEL BLOCKING AGENT; CONTRAST MEDIUM; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOPAMINE; FELODIPINE; FENOLDOPAM; FUROSEMIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOLOGIC FACTOR; IODINATED CONTRAST MEDIUM; IODIXANOL; IOHEXOL; IONIC CONTRAST MEDIUM; IOPAMIDOL; IOXITALAMIC ACID; MANNITOL; MISOPROSTOL; NITRENDIPINE; REACTIVE OXYGEN METABOLITE; THEOPHYLLINE; THROMBOXANE A2; UNINDEXED DRUG;

ANEMIA; BLEEDING; CARDIOLOGY; CLINICAL FEATURE; CLINICAL TRIAL; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; CREATININE BLOOD LEVEL; DIABETES MELLITUS; HUMAN; HYDRATION; KIDNEY BLOOD FLOW; KIDNEY CORTEX; KIDNEY DISEASE; KIDNEY MEDULLA; KIDNEY TUBULE DAMAGE; LOW DRUG DOSE; MEDICAL PRACTICE; OSMOLALITY; PATHOGENESIS; PATHOPHYSIOLOGY; PRECIPITATION; PROPHYLAXIS; REPERFUSION; RISK FACTOR; SCORING SYSTEM; VASOCONSTRICTION;

CONTRAST MEDIA; CREATINE; ENDOTHELIUM, VASCULAR; HUMANS; KIDNEY DISEASES; NITRIC OXIDE; RISK FACTORS; VASOCONSTRICTION;

EID: 48749121791     PISSN: 00194832     EISSN: 00194832     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (29)

1. Persson PB, Tepel M. Contrast medium-induced nephropathy: the pathophysiology. Proceedings of the Contrast-Induced Nephropathy Consensus Panel 17 Sept 2005, Paris. Kidney International, 2006;69(Suppl 100):S8-S10.
2. Quader MA, Sawmiller C, Sumpio BA. Contrast-induced nephropathy: review of incidence and pathophysiology. Ann Vasc Surg 1998;12:612-620.
3. Love L, Lind JA, Olson MC. Persistent CT nephrogram: significance in the diagnosis of contrast nephropathy. Radiology 1989;172:125-129.
4. Katzberg RW, Haller C. Contrast-induced nephrotoxicity: clinical landscape. Kidney Int 2006;69(Suppl 100):s3-s7.
5. Liss P, Nygren A, Erikson U, et al. Injection of low and iso- osmolality contrast medium decreases oxygen tension in the renal medulla. Kidney Int 1998;53:698-702.
6. Solomon R, Biguori C, Bettmann M. Selection of contrast media. Kidney Int 2006; 69(Suppl 100):s39-s45.
7. Hill JA. Multicenter trial of ionic versus nonionic contrast media for cardiac angiography. Am J Cardiol 1993;72:770.
8. Aspelin P, Aubry P, Fransson SG, et al. Nephrotoxicity in high-risk patients study of iso-osmolar and low-osmolar non-ionic contrast media study investigators. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 2003;348:491-499.
9. Ueda J, Nygren A, Hansell P, et al. Influence of contrast media on single nephron glomerular filtration rate in rat kidney. A comparison between diatrizoate, iohexol, ioxaglate, and iotrolan. Acta Radiol 1992;33:596-599.
10. Hizoh I , Strater J, Schick CS, et al. Radiocontrast induced DNA fragmentation of renal tubular cells in vitro: role of hypertonicity. Nephrol Dial Transplant 1998; 13:911-918.
11. Moreau JF, Droz D. Tubular nephrotoxicity of water-soluble iodinated contrast media. Invest Radiol 1980;15:S54.
12. Tumlin J, Stacul F, Adam A, et al. On behalf of the CIN Consensus Working Panel. Pathophysiology of contrast-induced nephropathy. Am J Cardiol 2006;98(Suppl):14K-20K.
13. Nygren A. Contrast media and regional renal blood flow: a study of the effects of ionic and non-ionic monomeric and dimeric contrast media in the rat. Acta Radiol Suppl 1992;378(Pt 3):123-135.
14. Gruberg L, Mehran R, Dangas G, et al. Acute renal failure requiring dialysis after percutaneous coronary interventions. Catheter Cardiovasc Interv 2001;52:409-416.
15. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
16. Nikolsky E, Mehran R, Turcot D, et al. Impact of chronic kidney disease on prognosis of patients with diabetes mellitus treated with percutaneous coronary intervention. Am J Cardiol 2004;94:300-305.
17. Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention : development and initial validation. J Am Coll Cardiol 2004;44:1393-1399.
18. Mueller C. Prevention of contrast-induced nephropathy with volume supplementation. Kidney Internat 2006;69(Suppl 100);S16-S19.
19. Mueller C, Buerkle G, Buettner HJ, et al. Prevention of contrast media-associated nephropathy: randomised comparison of two hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 2002;162:329-336.
20. Merten GJ, Burgess WP, Gray LV, et al. Prevention of contrast-induced nephropathy with sodium bicarbonate. A randomized controlled trial. JAMA 2004;291:2328-2334.
21. Tepel M, Van der Giet M, Schwarzfeld C, et al. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 2000;343:180-184.
22. Brick R, Krzossok S, Markowetz F, et al. Acetylcysteine for prevention of contrast nephropathy: meta-analysis. Lancet 2003; 362:598-603.
23. Spargias K, Alexopoulos E, Kyrzopoulos S, et al. Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. Circulation 2004;110:2837-2842.
24. Briguori C, Marenzi G. Contrast-induced nephropathy: pharmacological prophylaxis. Kidney Internat 2006; 69(Suppl 100):S30-S38.
25. Huber W, Jeschke B, Page M, et al. Reduced incidence of radiocontrast-induced nephropathy in ICU patients under theophylline prophylaxis: a prospective comparison to series of patients at similar risk. Intens Care Med 2001;27:1200-1209.
26. Ix JH, McCulloch CE, Chertow GM, et al. Theophylline for the prevention of radiocontrast nephropathy: meta-analysis. Nephrol Dial Transplant 2004;19:2747-2753.
27. Stone GW, McCullough PA, Tumlin JA, et al. Fenoldopam mesylate for the prevention of contrast-induced nephrotoxicity. JAMA 2003;290:2284-2291.
28. Stevens MA, McCullough PA, Tobin KJ, et al. A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the PRINCE study. J Am CollCardiol 1999;33:403-411.
29. Solomon R, Deray G. How to prevent contrast-induced nephropathy and manage risk patients: Practical recommendations. Kidney Internat 2006;69(Suppl 100):S51-S53.